Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream

被引：0
|
作者：
Mazzetti, Alessandro [1 ]
Kyeremateng, Kizito [2 ,3 ]
Moro, Luigi [1 ]
机构：
[1] Cassiopea SpA, Lainate, Italy
[2] Sun Pharmaceut Ind Inc, Princeton, NJ USA
[3] Sun Pharmaceut Ind Inc, 2 Independence Way,2nd Floor, Princeton, NJ 08540 USA
来源：
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2023年 / 16卷
关键词：
TOPICAL CREAM; OPEN-LABEL;
D O I：
10.2147/CCID.S451433
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：3651 / 3652
页数：2
相关论文
共 50 条
  • [1] Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
    Sanchez, Carol
    Keri, Jonette
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1357 - 1366
  • [2] EFFICACY AND SAFETY OF CLASCOTERONE CREAM 1% IN PATIENTS WITH ACNE VULGARIS ACROSS SUBGROUPS DEFINED BY DEMOGRAPHIC CHARACTERISTICS
    Eichenfield, L. F.
    Hebert, A. A.
    Stein, Gold L.
    Cartwright, M.
    Moro, L.
    Han, J.
    Squittieri, N.
    Mazzetti, A.
    VALUE IN HEALTH, 2023, 26 (06) : S29 - S29
  • [3] Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics
    Eichenfield, Lawrence
    Hebert, Adelaide
    Thiboutot, Diane
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 4 - 5
  • [4] Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Thiboutot, Diane
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB41 - AB41
  • [5] Long-term safety and efficacy of 1% clascoterone cream in patients ≥12 years old with acne vulgaris
    Eichenfield, Lawrence
    Hebert, Adelaide
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 4 - 4
  • [6] Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older
    Gold, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (04) : 301 - 308
  • [7] Clascoterone 1% cream in acne vulgaris: a profile of its use
    Esther S. Kim
    Susan J. Keam
    Drugs & Therapy Perspectives, 2021, 37 : 194 - 198
  • [8] Clascoterone 1% cream in acne vulgaris: a profile of its use
    Kim, Esther S.
    Keam, Susan J.
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (05) : 194 - 198
  • [9] Long-term safety and efficacy of 1% clascoterone cream in patients <12 years old with acne vulgaris
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Gold, Linda Stein
    Cartwright, Martina
    Moro, Luigi
    Han, Jenny
    Squittieri, Nicholas
    Mazzetti, Alessandro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB190 - AB190
  • [10] Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris
    Cartwright, Martina
    Moro, Luigi
    Fragasso, Enrico
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB49 - AB49
12345